Suppr超能文献

老年和体弱房颤患者使用直接口服抗凝剂:抗凝服务的优势

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service.

作者信息

Vedovati Maria Cristina, Agnelli Giancarlo

机构信息

Internal Vascular and Emergency Medicine-Stroke Unit, University of Perugia, 06129 Perugia, Italy.

IRCCS Istituti Scientifici Maugeri, 27100 Pavia, Italy.

出版信息

J Pers Med. 2022 Aug 20;12(8):1339. doi: 10.3390/jpm12081339.

Abstract

Despite the recent advancements, oral anticoagulation is still challenging in some patients and this is the case for old and frail patients. The large majority of frail patients with atrial fibrillation should receive anticoagulation since the associated benefits outweigh the risk of bleeding. A multidisciplinary consensus document on the use and prescription of direct oral anticoagulants (DOACs) in older and frail patients with atrial fibrillation has been recently published. In this manuscript we provide a comment on this document and add insights into the management of these patients. The new DOAC age had imposed a paradigm shift in the management of patients with the need for clinically-oriented services rather than laboratory-oriented services. In this paper we provide tools for a structured patient-oriented DOACs treatment service supported by a multidisciplinary approach.

摘要

尽管最近有了进展,但口服抗凝治疗在一些患者中仍然具有挑战性,老年和体弱患者就是如此。绝大多数患有房颤的体弱患者都应接受抗凝治疗,因为相关益处大于出血风险。最近发表了一份关于老年和体弱房颤患者使用和处方直接口服抗凝剂(DOACs)的多学科共识文件。在本手稿中,我们对该文件发表评论,并补充对这些患者管理的见解。新的DOAC时代在需要临床导向服务而非实验室导向服务的患者管理中引发了范式转变。在本文中,我们提供了通过多学科方法支持的以患者为导向的结构化DOACs治疗服务工具。

相似文献

5
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007230. doi: 10.1161/CIRCOUTCOMES.120.007230. Epub 2021 Feb 5.
6
Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation.
Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):137-146. doi: 10.1093/ehjcvp/pvad091.
7
Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):428-434. doi: 10.1177/1074248419841634. Epub 2019 Apr 29.
8
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Circulation. 2023 Jun 6;147(23):1748-1757. doi: 10.1161/CIRCULATIONAHA.122.062752. Epub 2023 Apr 12.
9
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Circulation. 2018 Oct 2;138(14):1402-1411. doi: 10.1161/CIRCULATIONAHA.117.031457.
10
Use of DOACs in real-world challenging settings: a Delphi Consensus from Italian cardiologists.
Minerva Cardioangiol. 2019 Oct;67(5):361-373. doi: 10.23736/S0026-4725.19.04985-5. Epub 2019 Jul 24.

本文引用的文献

7
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.
N Engl J Med. 2020 Oct 29;383(18):1735-1745. doi: 10.1056/NEJMoa2012883. Epub 2020 Aug 30.
9
Direct oral anticoagulants for patients aged over 80 years in nonvalvular atrial fibrillation: the impact of frailty.
J Cardiovasc Med (Hagerstown). 2020 Aug;21(8):562-569. doi: 10.2459/JCM.0000000000000986.
10
Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study.
Int J Cardiol. 2019 Apr 15;281:56-61. doi: 10.1016/j.ijcard.2019.01.071. Epub 2019 Jan 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验